FDA approves Novartis's drug for painful skin disease

January 21, 2015 5:52 PM

4 0

FDA approves Novartis's drug for painful skin disease

(Reuters) - The U.S. Food and Drug Administration approved Novartis AG's injectable drug, Cosentyx, to treat adults with a moderate to severe skin disease called plaque psoriasis.

Cosentyx was approved on Wednesday with a medication guide warning about a greater risk of infection as it affects the immune system.

Also read: Texas Gives Herman 5 Years, Minimum of $25 Million

Read more

To category page

Loading...